medium chain triglyceride oil

DIETARY_SUPPLEMENT6 trials

Sponsors

Pennington Biomedical Research Center, British Columbia Children's Hospital, University of Alberta, The Canadian College of Naturopathic Medicine, Université de Sherbrooke

Conditions

Covid19First Episode PsychosisLong COVIDMild Cognitive ImpairmentPharmacokineticsShort Bowel Syndrome

Phase 3

Dietary Supplements for COVID-19

TerminatedNCT04780061

The Canadian College of Naturopathic MedicineCovid19

Start: 2021-07-12End: 2022-07-07Updated: 2024-09-19

Unknown Phase

Effect of Medium Chain Triglyceride Oil Supplementation in Mild Cognitive Impairment

CompletedNCT01669200

Pennington Biomedical Research CenterMild Cognitive Impairment

Start: 2012-08-31End: 2014-10-31Updated: 2022-09-29

Probiotics in Short Bowel Syndrome

CompletedNCT03980327

British Columbia Children's HospitalShort Bowel Syndrome

Start: 2017-01-04End: 2018-12-31Updated: 2019-06-11

Ketone Levels Achieved After Medium Chain Triglyceride (MCT) Oil

CompletedNCT04389983

University of AlbertaPharmacokinetics

Start: 2019-05-02End: 2020-04-15Updated: 2020-05-15

Nutritional Management of Post COVID-19 Cognitive Symptoms

RecruitingNCT05705648

University of AlbertaLong COVID

Start: 2023-10-01End: 2027-03-01Target: 100Updated: 2025-07-08

Recovery With Exogenous Ketones and Antipsychotics

Not yet recruitingNCT07122531

Université de SherbrookeFirst Episode Psychosis

Start: 2025-08-25End: 2027-08-15Target: 15Updated: 2025-08-14

Related Papers

Dietary supplements to reduce symptom severity and duration in people with SARS-CoV-2: a double-blind randomised controlled trial

BMJ Open2023-09-016 citations

Dietary supplements to reduce symptom severity and duration in people with SARS-CoV-2: study protocol for a randomised, double-blind, placebo controlled clinical trial

BMJ Open2022-03-015 citations